TipRanks
Inhibikase Therapeutics (IKT)
NASDAQ:IKT
IKT
Inhibikase Therapeutics
RESEARCH TOOLSreports
Want to see IKT full AI Analyst Report?

Inhibikase Therapeutics (IKT) Revenue

382 Followers
StatisticsMarket CapRevenue

Inhibikase Therapeutics Revenue

Inhibikase Therapeutics had a revenue of 0.00 in the quarter ending Jun 30, 2026, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Dec 31, 2025, Inhibikase Therapeutics had annual revenue of 0.00 with ― growth.
Revenue (ttm)
0.00
Revenue Growth
―
P/S Ratio
―
Revenue/Employee
$0
Employees
35
Market Cap
$281.86M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
―――
Dec 31, 2024
―-260.50K-100.00%
Dec 31, 2023
260.50K137.06K+111.03%
Mar 31, 2023
123.44K-2.98M-96.02%
Mar 31, 2022
3.10M2.40M+343.92%
Mar 31, 2021
698.47K-424.27K-37.79%
Dec 31, 2019
1.12M-2.92M-72.22%
Dec 31, 2018
4.04M1.98M+96.07%
Dec 31, 2017
2.06M――